Latest News

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Cardiovascular Disease, Heart Disease, Metabolism, biomarkers

Search for Novel Biomarkers Indicating Early Cardiovascular Disease Risk Wins Funding to Design Larger Scale Study in People of Mexican Ancestry

PIC_11-17_LABPOR_KentBastarrachea_02.jpg

Texas Biomedical Research Institute scientists have been granted funding from the National Institutes of Health to pursue a promising study on the ultimate causes of heart disease and metabolic disorders.

Science

Channels:

Cardiovascular Disease, Heart Disease, biomarkers, Metabolism

La Búsqueda de Nuevos Biomarcadores que Indiquen el Riesgo de una Enfermedad Cardiovascular Temprana Gana una Beca para el Diseño de un Estudio a Mayor Escala en Personas de Ascendencia Mexicana

PIC_11-17_LABPOR_KentBastarrachea_02.jpg

A los científicos del Texas Biomedical Research Institute (Instituto de Investigación Biomédica de Texas) les han otorgado una beca por parte del National Institutes of Health (NIH) (Institutos Nacionales de Salud) para llevar a cabo un estudio prometedor sobre las causas principales de enfermedades del corazón y los trastornos metabólicos.

Medicine

Channels:

Hepatitis B, Hepatitis B research, HBV, hepatitis B virus (HBV), Primate Research, nonhuman primates

Promising New Drug for Hepatitis B Tested First at Texas Biomedical Research Institute’s National Primate Research Center in San Antonio

Dr.Lanfordinlab.jpg

Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.

Science

Business

Channels:

tuberculoisis, Tuberculosis, Tuberculosis research

Researcher on TB and the Intersection of Aging and Immune Function Joins Texas Biomed as Vice President for Research

JoanneTurner.jpg

Joanne Turner, Ph.D., a preeminent scientist in tuberculosis (TB) research, has joined the Texas Biomed team, bringing with her a portfolio of research on the immune system in relation to Mycobacterium tuberculosis infection and aging.

Science

Channels:

microRNA biomarker, Neuropsychiatric Disorders

Researcher Receives NIH Grant to Study Biomarkers of Variation in Brain Regions Important to Neuropsychiatric Disorders

Associate Scientist Melanie Carless, Ph.D., has been funded by the National Institute of Mental Health to identify microRNA biomarkers in the blood and cerebrospinal fluid that are associated with changes in the brain correlated to neuropsychiatric disorders, using a non-human primate model.

Business

Channels:

Malaria, Malaria Drug Resistance

Texas Biomed Scientists part of $11.5 million NIH project aimed at combatting drug resistance in the malaria parasite

Texas Biomedical Research Institute researchers, Dr. Tim Anderson and Dr. Ian Cheeseman, have partnered with researchers at the University of Notre Dame and the Center for Infectious Disease Research in Seattle to pursue studies in drug resistant malaria.

Medicine

Channels:

Tubercolosis, TB, tuberculosis vaccine, TB Vaccine

Texas Biomed Part of Team Receiving Five-Year, $4.4 Million NIH Grant for Novel TB Vaccine Testing

DSC_0012.JPG

Texas Biomedical Research Institute UTHealth in Houston partner to test a modified TB vaccine that, if effective, could prove more powerful and provide longer lasting immunity.

Medicine

Channels:

Texas Biomed Part of Research Efforts to Screen and Develop Ebola Virus Drug

texas-biomedical-research-1051x700.jpg

Dr. Robert Davey, Scientist at Texas Biomedical Research Institute, is part of a team of researchers working to find new drugs that will stop Ebola virus from growing inside infected cells. Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $4.1 million federal grant for this project.

Business

Channels:

Texas, tuberculoisis, Tuberculosis, Lung Disease

Texas Biomed Names Larry Schlesinger, M.D. As President/CEO

DrLarrySchlesinger_1.jpg

Texas Biomedical Research Institute announced that its Board of Trustees has named Dr. Larry Schlesinger as the Institute’s new President and CEO. Dr. Schlesinger will take the helm of Texas Biomed effective May 31, 2017.

Science

Channels:

Malaria, Drug Resistance, Malaria Drug Resistance

Texas Biomed Scientist Receives 5-Year, $4.6 Million Merit Award From NIH for Malaria Research

Dr.TimAnderson2.jpg

Dr. Timothy Anderson, Scientist in the Department of Genetics at Texas Biomedical Research Institute, received a five-year, $4.6 million MERIT Award from the National Institutes of Health.







Chat now!